4-[1-(4-Propan-2-ylphenyl)pyrazol-4-yl]pyrimidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-[1-(4-Propan-2-ylphenyl)pyrazol-4-yl]pyrimidine
• 化学式: C₁₆H₁₆N₄
• 分子量: 264.32
• InChiKey: XEVZGUWUUNDBJY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  43.6
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
  申请人：Cosford D.P. Nicholas

  公开号：US20050026963A1

  公开（公告）日：2005-02-03

  Pyrazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, bipolar disorder and panic, as well as in the treatment of pain, circadian rhythm disorders, and other diseases.

  直接或通过桥连接的杂环芳基团，其中含有N相邻于杂环芳基连接点的吡唑化合物，是mGluR5调节剂，可用于治疗精神和情绪障碍，例如精神分裂症、焦虑、抑郁、双相障碍和恐慌，以及用于治疗疼痛、昼夜节律失调和其他疾病。
• IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20140206675A1

  公开（公告）日：2014-07-24

  In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): (I) and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R 1 , R 2 , R 3 , R 4 , R 5 , R 9 , ring A, ring B, m, n, p, -L 1 -, L 2 -, and L 3 - is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (Aβ) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination nation with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimers disease, are also disclosed.

  在其不同实施例中，本发明提供某些亚氨基噻二嗪二氧化物化合物，包括化合物公式（I）：（I），并包括其立体异构体和药学上可接受的盐，其中R1、R2、R3、R4、R5、R9、环A、环B、m、n、p、-L1-、L2-和L3-各自独立选择并按照定义选定。本发明的新型亚氨基噻二嗪二氧化物化合物出人意料地发现具有预期的性质，这些性质使它们有望成为BACE抑制剂和/或用于治疗和预防与β-淀粉样蛋白（Aβ）产生相关的各种病理的优势。本发明还揭示了包括一个或多个此类化合物（独立和与一个或多个其他活性剂联合使用）的药物组合物，并揭示了用于制备和治疗与淀粉样β（Aβ）蛋白相关的病理，包括阿尔茨海默病的方法。
• HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5
  申请人：Merck & Co., Inc.

  公开号：EP1458383A2

  公开（公告）日：2004-09-22
• EP1458383A4
  申请人：——

  公开号：EP1458383A4

  公开（公告）日：2005-05-25
• US7569592B2
  申请人：——

  公开号：US7569592B2

  公开（公告）日：2009-08-04